寶沙發展(01069.HK):法院頒令將呈請聆訊進一步押後至3月3日
格隆匯1月27日丨寶沙發展(01069.HK)公吿稱,於2021年1月27日的聆訊,法院頒令將該呈請的聆訊進一步押後至2021年3月3日。
此外,公司已根據該呈請申請就轉讓公司股份申請認可令,及法院已授出認可令,批准公司於聯交所上市的已發行股份的所有買賣,不論是否通過香港中央結算有限公司所營運的中央結算及交收系統進行,亦不論在聯交所的場內或場外進行,公司股東狀況的相應變動概不會根據公司(清盤及雜項條文)條例(第32章)第182條的呈請規定而失效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.